| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pathology and Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114
This paper describes the histogenesis of 3 forms of human malignant melanoma: superficial spreading melanoma, nodular melanoma, and lentigo maligna melanoma. A comparative analysis by computer of the biologic behavior and clinical characteristics of the different neoplasms has been done. An additional 60 tumors have been studied by serial block sectioning. Evidence is presented suggesting that superficial spreading melanoma and lentigo maligna melanoma (Hutchinson's melanotic freckle), though evolving at different rates, show a long period of superficial growth, followed by the relatively rapid appearance of nodules or deeper invasion within the primary lesion. This change in the nature of the primary lesion may be due to the appearance of one or more strains of cells of aggressive biologic potential. Thus the primary melanoma may exist for a relatively long period of time during which host selectional forces act to permit the growth of quite malignant strains of cells. It is these cells that seem to be capable of deeper growth. The subdivision of each of the forms of melanoma into 5 anatomic levels of invasion permits the accurate assignment of prognosis to each case. It is suggested that melanomas are tumors of the epidermal melanocytes and are not necessarily derived from melanocytic nevi. Each melanoma has a distinctive clinical appearance, even in its superficial and curable phases, and this appearance is the same whether or not the process arose in association with a melanocytic nevus.
1 Supported by grants from the National Cancer Institute CA-06221, the Massachusetts Division of the American Cancer Society, and the Damon Runyon Fund.
2 Present address: Temple University School of Medicine, Dept. of Pathology, 3420 N. Broad St., Philadelphia, Pennsylvania 19140.
Received 7/ 8/68. Accepted 11/ 4/68.
This article has been cited by other articles:
|
|
 |
|
  C. Fonseca and G. Dranoff Capitalizing on the Immunogenicity of Dying Tumor Cells Clin. Cancer Res., March 15, 2008; 14(6): 1603 - 1608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Tucker Is Sunlight Important to Melanoma Causation? Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 467 - 468. [Full Text] [PDF]
|
|
|
|
 |
|
 V. E. Sugiyama, J. K. Chan, J. Y. Shin, J. S. Berek, K. Osann, and D. S. Kapp Vulvar Melanoma: A Multivariable Analysis of 644 Patients Obstet. Gynecol., August 1, 2007; 110(2): 296 - 301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. E. Thomas, S. N. Edmiston, A. Alexander, R. C. Millikan, P. A. Groben, H. Hao, D. Tolbert, M. Berwick, K. Busam, C. B. Begg, et al. Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 991 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Fecher, S. D. Cummings, M. J. Keefe, and R. M. Alani Toward a Molecular Classification of Melanoma J. Clin. Oncol., April 20, 2007; 25(12): 1606 - 1620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Liu, J. P. Dowling, W. K. Murray, G. A. McArthur, J. F. Thompson, R. Wolfe, and J. W. Kelly Rate of Growth in Melanomas: Characteristics and Associations of Rapidly Growing Melanomas Arch Dermatol, December 1, 2006; 142(12): 1551 - 1558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Elder Pathology of melanoma. Clin. Cancer Res., April 1, 2006; 12(7): 2308s - 2311s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. S. Hodi Well-Defined Melanoma Antigens as Progression Markers for Melanoma: Insights into Differential Expression and Host Response Based on Stage Clin. Cancer Res., February 1, 2006; 12(3): 673 - 678. [Full Text] [PDF]
|
|
|
|
|
|
I. M. Bachmann, O. Straume, H. E. Puntervoll, M. B. Kalvenes, and L. A. Akslen Importance of P-Cadherin, {beta}-Catenin, and Wnt5a/Frizzled for Progression of Melanocytic Tumors and Prognosis in Cutaneous Melanoma Clin. Cancer Res., December 15, 2005; 11(24): 8606 - 8614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Curtin, J. Fridlyand, T. Kageshita, H. N. Patel, K. J. Busam, H. Kutzner, K.-H. Cho, S. Aiba, E.-B. Brocker, P. E. LeBoit, et al. Distinct Sets of Genetic Alterations in Melanoma N. Engl. J. Med., November 17, 2005; 353(20): 2135 - 2147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Gimotty, P. Van Belle, D. E. Elder, T. Murry, K. T. Montone, X. Xu, S. Hotz, S. Raines, M. E. Ming, P. Wahl, et al. Biologic and Prognostic Significance of Dermal Ki67 Expression, Mitoses, and Tumorigenicity in Thin Invasive Cutaneous Melanoma J. Clin. Oncol., November 1, 2005; 23(31): 8048 - 8056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Van Marck, C. Stove, K. Van Den Bossche, V. Stove, J. Paredes, Y. Vander Haeghen, and M. Bracke P-Cadherin Promotes Cell-Cell Adhesion and Counteracts Invasion in Human Melanoma Cancer Res., October 1, 2005; 65(19): 8774 - 8783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Banky, J. W. Kelly, D. R. English, J. M. Yeatman, and J. P. Dowling Incidence of New and Changed Nevi and Melanomas Detected Using Baseline Images and Dermoscopy in Patients at High Risk for Melanoma Arch Dermatol, August 1, 2005; 141(8): 998 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Kesmodel, G. C. Karakousis, J. D. Botbyl, R. J. Canter, R. T. Lewis, P. M. Wahl, K. P. Terhune, A. Alavi, D. E. Elder, M. E. Ming, et al. Mitotic Rate as a Predictor of Sentinel Lymph Node Positivity in Patients With Thin Melanomas Ann. Surg. Oncol., June 1, 2005; 12(6): 449 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-F. Demierre, C. Chung, D. R. Miller, and A. C. Geller Early Detection of Thick Melanomas in the United States: Beware of the Nodular Subtype Arch Dermatol, June 1, 2005; 141(6): 745 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Hawkins, K. J. Busam, L. Ben-Porat, K. S. Panageas, D. G. Coit, D. E. Gyorki, D. C. Linehan, and M. S. Brady Desmoplastic Melanoma: A Pathologically and Clinically Distinct Form of Cutaneous Melanoma Ann. Surg. Oncol., March 1, 2005; 12(3): 207 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nambiar, A. Mirmohammadsadegh, R. Doroudi, A. Gustrau, A. Marini, G. Roeder, T. Ruzicka, and U. R. Hengge Signaling Networks in Cutaneous Melanoma Metastasis Identified by Complementary DNA Microarrays Arch Dermatol, February 1, 2005; 141(2): 165 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Balch, S.-J. Soong, M. B. Atkins, A. C. Buzaid, N. Cascinelli, D. G. Coit, I. D. Fleming, J. E. Gershenwald, A. Houghton Jr., J. M. Kirkwood, et al. An Evidence-based Staging System for Cutaneous Melanoma CA Cancer J Clin, May 1, 2004; 54(3): 131 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Bastian, A. B. Olshen, P. E. LeBoit, and D. Pinkel Classifying Melanocytic Tumors Based on DNA Copy Number Changes Am. J. Pathol., November 1, 2003; 163(5): 1765 - 1770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Pham, T Milovanovic, R J Barr, T Truong, and R F Holcombe Wnt ligand expression in malignant melanoma: pilot study indicating correlation with histopathological features Mol. Pathol., October 1, 2003; 56(5): 280 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Szenajch, B. Jasinski, A. Synowiec, J. Kulik, M. Chomicka, J. Struzyna, Z. Nowecki, P. Rutkowski, W. Ruka, W. Kupsc, et al. Prognostic Value of Multiple Reverse Transcription-PCR Tyrosinase Testing for Circulating Neoplastic Cells in Malignant Melanoma Clin. Chem., September 1, 2003; 49(9): 1450 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Eskandarpour, J. Hashemi, L. Kanter, U. Ringborg, A. Platz, and J. Hansson Frequency of UV-Inducible NRAS Mutations in Melanomas of Patients With Germline CDKN2A Mutations J Natl Cancer Inst, June 4, 2003; 95(11): 790 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Dadras, T. Paul, J. Bertoncini, L. F. Brown, A. Muzikansky, D. G. Jackson, U. Ellwanger, C. Garbe, M. C. Mihm, and M. Detmar Tumor Lymphangiogenesis: A Novel Prognostic Indicator for Cutaneous Melanoma Metastasis and Survival Am. J. Pathol., June 1, 2003; 162(6): 1951 - 1960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Lowe, E. Hurst, J. F. Moley, and L. A. Cornelius Sentinel Lymph Node Biopsy in Patients With Thin Melanoma Arch Dermatol, May 1, 2003; 139(5): 617 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Govindarajan, X. Bai, C. Cohen, H. Zhong, S. Kilroy, G. Louis, M. Moses, and J. L Arbiser Malignant Transformation of Melanocytes to Melanoma by Constitutive Activation of Mitogen-activated Protein Kinase Kinase (MAPKK) Signaling J. Biol. Chem., March 7, 2003; 278(11): 9790 - 9795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Chamberlain, L. Fritschi, G. G. Giles, J. P. Dowling, and J. W. Kelly Nodular Melanoma Is Not a Distinct Entity--Reply Arch Dermatol, March 1, 2003; 139(3): 387 - 388. [Full Text] [PDF]
|
|
|
|
|
|
R. Clarijs, L. Schalkwijk, U. B. Hofmann, D. J. Ruiter, and R. M. W. de Waal Induction of Vascular Endothelial Growth Factor Receptor-3 Expression on Tumor Microvasculature as a New Progression Marker in Human Cutaneous Melanoma Cancer Res., December 1, 2002; 62(23): 7059 - 7065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Straume, J. Smeds, R. Kumar, K. Hemminki, and L. A. Akslen Significant Impact of Promoter Hypermethylation and the 540 C>T Polymorphism of CDKN2A in Cutaneous Melanoma of the Vertical Growth Phase Am. J. Pathol., July 1, 2002; 161(1): 229 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Chamberlain, L. Fritschi, G. G. Giles, J. P. Dowling, and J. W. Kelly Nodular Type and Older Age as the Most Significant Associations of Thick Melanoma in Victoria, Australia Arch Dermatol, May 1, 2002; 138(5): 609 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Balch and M. C. Mihm Reply to the article "The AJCC staging proposal for cutaneous melanoma: comments by the EORTC Melanoma Group", by D. J. Ruiter et al. (Ann Oncol 2001; 12: 9-11) Ann. Onc., January 19, 2002; 13(1): 175 - 176. [Full Text] [PDF]
|
|
|
|
|
|
C. M. Balch, A. C. Buzaid, S.-J. Soong, M. B. Atkins, N. Cascinelli, D. G. Coit, I. D. Fleming, J. E. Gershenwald, A. Houghton Jr, J. M. Kirkwood, et al. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma J. Clin. Oncol., August 15, 2001; 19(16): 3635 - 3648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Busam, K. Hester, C. Charles, D. L. Sachs, C. R. Antonescu, S. Gonzalez, and A. C. Halpern Detection of Clinically Amelanotic Malignant Melanoma and Assessment of Its Margins by In Vivo Confocal Scanning Laser Microscopy Arch Dermatol, July 1, 2001; 137(7): 923 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Calonje Best practice No 162 The histological reporting of melanoma J. Clin. Pathol., August 1, 2000; 53(8): 587 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. DHAR-MUNSHI, M AMEEN, and R. S WILSON Simultaneous metastases of cutaneous malignant melanoma to conjunctiva and choroid Br. J. Ophthalmol., August 1, 2000; 84(8): 928b - 928. [Full Text]
|
|
|
|
|
|
O. Straume, L. Sviland, and L. A. Akslen Loss of Nuclear p16 Protein Expression Correlates with Increased Tumor Cell Proliferation (Ki-67) and Poor Prognosis in Patients with Vertical Growth Phase Melanoma Clin. Cancer Res., May 1, 2000; 6(5): 1845 - 1853. [Abstract] [Full Text]
|
|
|
|
|
|
L. C. L. T. van Kempen, J. J. van den Oord, G. N. P. van Muijen, U. H. Weidle, H. P. J. Bloemers, and G. W. M. Swart Activated Leukocyte Cell Adhesion Molecule/CD166, a Marker of Tumor Progression in Primary Malignant Melanoma of the Skin Am. J. Pathol., March 1, 2000; 156(3): 769 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. HOVE and L. A. AKSLEN Clinicopathological Characteristics of Melanomas of the Hand J Hand Surg Eur Vol., August 1, 1999; 24(4): 460 - 464. [Abstract] [PDF]
|
|
|
|
|
|
S. Syngal and S. Kaptain Case 7-1999- A 50-Year-Old Woman with Severe Diarrhea during Radiation Treatment for Resected Metastatic Melanoma N. Engl. J. Med., March 11, 1999; 340(10): 789 - 796. [Full Text] [PDF]
|
|
|
|
|
|
A. Spatz, E. Calonje, S. Handfield-Jones, and R. L. Barnhill Spitz Tumors in Children: A Grading System for Risk Stratification Arch Dermatol, March 1, 1999; 135(3): 282 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hemo, M. Gutman, and J. M. Klausner Anatomic Site of Primary Melanoma Is Associated With Depth of Invasion Arch Surg, February 1, 1999; 134(2): 148 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Soiffer, T. Lynch, M. Mihm, K. Jung, C. Rhuda, J. C. Schmollinger, F. S. Hodi, L. Liebster, P. Lam, S. Mentzer, et al. Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma PNAS, October 27, 1998; 95(22): 13141 - 13146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. BANZET, J. GLICENSTEIN, and C. DUFOURMENTEL Melanotic Tumours of the Hand J Hand Surg Eur Vol., April 1, 1975; 7(2): 183 - 184. [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
